Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BBC
Virtus LifeSci Biotech Clinical Trials ETF
$48.74
-3.0%
$47.81
$20.87
$54.95
$46.30M0.8624,062 shs14,729 shs
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
$28.05
-2.3%
$27.23
$22.80
$30.33
$44.88M0.7411,704 shs4,928 shs
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
$27.96
-0.8%
$0.00
$23.85
$28.31
$1.40M-1.77860 shs64 shs
Mastercard Incorporated stock logo
MA
Mastercard
$573.64
-0.6%
$514.87
$464.52
$601.77
$510.14B0.732.83 million shs4.58 million shs
Visa Inc. stock logo
V
Visa
$366.33
+0.0%
$341.12
$293.89
$373.97
$657.00B0.757.34 million shs7.82 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BBC
Virtus LifeSci Biotech Clinical Trials ETF
+3.80%-0.08%-4.59%+14.51%+127.16%
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
+0.95%+0.63%+0.70%+15.76%+20.22%
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
+0.90%+2,817,999,900.00%+2,817,999,900.00%+2,817,999,900.00%+2,817,999,900.00%
Mastercard Incorporated stock logo
MA
Mastercard
+2.61%+9.02%+12.69%+14.74%+3.33%
Visa Inc. stock logo
V
Visa
-0.82%+4.26%+7.01%+10.88%+4.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BBC
Virtus LifeSci Biotech Clinical Trials ETF
$48.74
-3.0%
$47.81
$20.87
$54.95
$46.30M0.8624,062 shs14,729 shs
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
$28.05
-2.3%
$27.23
$22.80
$30.33
$44.88M0.7411,704 shs4,928 shs
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
$27.96
-0.8%
$0.00
$23.85
$28.31
$1.40M-1.77860 shs64 shs
Mastercard Incorporated stock logo
MA
Mastercard
$573.64
-0.6%
$514.87
$464.52
$601.77
$510.14B0.732.83 million shs4.58 million shs
Visa Inc. stock logo
V
Visa
$366.33
+0.0%
$341.12
$293.89
$373.97
$657.00B0.757.34 million shs7.82 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BBC
Virtus LifeSci Biotech Clinical Trials ETF
+3.80%-0.08%-4.59%+14.51%+127.16%
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
+0.95%+0.63%+0.70%+15.76%+20.22%
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
+0.90%+2,817,999,900.00%+2,817,999,900.00%+2,817,999,900.00%+2,817,999,900.00%
Mastercard Incorporated stock logo
MA
Mastercard
+2.61%+9.02%+12.69%+14.74%+3.33%
Visa Inc. stock logo
V
Visa
-0.82%+4.26%+7.01%+10.88%+4.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BBC
Virtus LifeSci Biotech Clinical Trials ETF
2.73
Moderate Buy$48.74N/A
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
2.71
Moderate Buy$28.05N/A
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
0.00
N/AN/AN/A
Mastercard Incorporated stock logo
MA
Mastercard
3.10
Buy$657.3314.59% Upside
Visa Inc. stock logo
V
Visa
3.23
Buy$411.7712.40% Upside

Current Analyst Ratings Breakdown

Latest BBC, FMED, V, MA, and LATR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Boost Price TargetOutperform$629.00 ➝ $642.00
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Boost Price TargetBuy$664.00 ➝ $667.00
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Reiterated RatingOutperform$632.00
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Boost Price TargetBuy$640.00 ➝ $670.00
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Boost Price TargetOverweight$679.00 ➝ $681.00
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Boost Price TargetOverweight$640.00 ➝ $660.00
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Boost Price TargetOutperform$665.00 ➝ $685.00
7/31/2026
Mastercard Incorporated stock logo
MA
Mastercard
Boost Price TargetOverweight$670.00 ➝ $680.00
7/30/2026
Mastercard Incorporated stock logo
MA
Mastercard
Reiterated RatingBuy$701.00
7/30/2026
Visa Inc. stock logo
V
Visa
UpgradeBuy (B-)Buy (B)
7/30/2026
Visa Inc. stock logo
V
Visa
Reiterated RatingOverweight$412.00 ➝ $432.00
(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/AN/AN/AN/AN/AN/A
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
N/AN/AN/AN/AN/AN/A
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
N/AN/AN/AN/AN/AN/A
Mastercard Incorporated stock logo
MA
Mastercard
$32.79B15.46$20.73 per share27.67$6.34 per share90.48
Visa Inc. stock logo
V
Visa
$40B16.43$13.05 per share28.08$19.33 per share18.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
N/AN/A41.33N/AN/AN/AN/AN/AN/A
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Mastercard Incorporated stock logo
MA
Mastercard
$14.97B$17.2831.5525.261.8146.34%239.99%30.88%N/A
Visa Inc. stock logo
V
Visa
$20.06B$11.7631.1524.541.9850.78%67.68%25.45%N/A

Latest BBC, FMED, V, MA, and LATR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Mastercard Incorporated stock logo
MA
Mastercard
$4.77$5.04+$0.27$4.97$9.08 billion$9.28 billion
7/28/2026Q3 2026
Visa Inc. stock logo
V
Visa
$3.23$3.32+$0.09$2.77$11.40 billion$11.63 billion
4/30/2026Q1 2026
Mastercard Incorporated stock logo
MA
Mastercard
$4.41$4.60+$0.19$4.35$8.26 billion$8.40 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BBC
Virtus LifeSci Biotech Clinical Trials ETF
$0.651.33%N/AN/AN/A
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
$0.110.39%N/AN/AN/A
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
N/AN/AN/AN/AN/A
Mastercard Incorporated stock logo
MA
Mastercard
$3.480.61%+13.70%20.14%13 Years
Visa Inc. stock logo
V
Visa
$2.680.73%+14.48%22.79%17 Years

Latest BBC, FMED, V, MA, and LATR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
Visa Inc. stock logo
V
Visa
quarterly$0.670.73%8/11/20268/11/20269/1/2026
6/16/2026
Mastercard Incorporated stock logo
MA
Mastercard
quarterly$0.870.67%7/9/20267/9/20268/7/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/AN/AN/A
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
N/AN/AN/A
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
N/AN/AN/A
Mastercard Incorporated stock logo
MA
Mastercard
3.96
1.06
0.98
Visa Inc. stock logo
V
Visa
0.60
0.99
1.09
CompanyEmployeesShares OutstandingFree FloatOptionable
BBC
Virtus LifeSci Biotech Clinical Trials ETF
N/A950,000N/ANot Optionable
Fidelity Disruptive Medicine ETF stock logo
FMED
Fidelity Disruptive Medicine ETF
N/A1.60 millionN/ANot Optionable
Corgi Buy Now Pay Later ETF stock logo
LATR
Corgi Buy Now Pay Later ETF
N/A50,000N/AN/A
Mastercard Incorporated stock logo
MA
Mastercard
39,800883.58 million882.79 millionOptionable
Visa Inc. stock logo
V
Visa
34,1001.79 billion1.79 billionOptionable

Recent News About These Companies

Will Rising Costs Overshadow Global Payments' Q2 Earnings?
Groupe la Francaise Sells 15,205 Shares of Visa Inc. $V
Visa (NYSE:V) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Cantor Fitzgerald Reiterates "Overweight" Rating for Visa (NYSE:V)
Visa says AI is helping to enable workforce cuts
Elon Musk aims at Venmo with one bold perk
Visa Vs. Mastercard: The Duel Just Got More Interesting
Visa vs PayPal: The Post Earnings Winner

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

Virtus LifeSci Biotech Clinical Trials ETF NYSEARCA:BBC

$48.74 -1.53 (-3.04%)
As of 04:10 PM Eastern

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.

Fidelity Disruptive Medicine ETF stock logo

Fidelity Disruptive Medicine ETF NASDAQ:FMED

$28.05 -0.67 (-2.33%)
As of 03:51 PM Eastern

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.

Corgi Buy Now Pay Later ETF stock logo

Corgi Buy Now Pay Later ETF NYSEARCA:LATR

$27.96 -0.22 (-0.78%)
As of 04:10 PM Eastern

Mastercard stock logo

Mastercard NYSE:MA

$573.64 -3.71 (-0.64%)
Closing price 03:59 PM Eastern
Extended Trading
$572.08 -1.56 (-0.27%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company offers integrated products and value-added services for account holders, merchants, financial institutions, digital partners, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; payment products and solutions that allow its customers to access funds in deposit and other accounts; prepaid programs services; and commercial credit, debit, and prepaid payment products and solutions. It also provides solutions that enable businesses or governments to make payments to businesses, including Virtual Card Number, which is generated dynamically from a physical card and leverages the credit limit of the funding account; a platform to optimize supplier payment enablement campaigns for financial institutions; and treasury intelligence platform that offers corporations with recommendations to enhance working capital performance and accelerate spend on cards. In addition, the company offers Mastercard Send, which partners with digital messaging and payment platforms to enable consumers to send money directly within applications to other consumers; and Mastercard Cross-Border Services enables a range of payment flows through a distribution network with a single point of access to send and receive money globally through various channels, including bank accounts, mobile wallets, cards, and cash payouts. Further, it provides cyber and intelligence solutions; insights and analytics, consulting, marketing, loyalty, processing, and payment gateway solutions for e-commerce merchants; and open banking and digital identity services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus name. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.

Visa stock logo

Visa NYSE:V

$366.33 +0.06 (+0.02%)
Closing price 03:59 PM Eastern
Extended Trading
$365.53 -0.80 (-0.22%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, deposit accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource that provides modular and value-added services for connecting merchants to payment processing; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Risk and Decision Manager, Visa Consumer Authentication Service, and payment-decisioning solutions for fraud prevention; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brand names. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California.